Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Chronic Kidney Disease|June 21, 2008
Bone morphogenetic protein 7 (BMP7): a critical role in kidney development and a putative modulator of kidney injuryPatrick Archdeacon, Randal K Detwiler
Transplantation|February 6, 2013
FDA perspective: enrolment of elderly transplant recipients in clinical trialsJoette M Meyer, Patrick Archdeacon, Renata Albrecht
Nature Reviews. Drug Discovery|November 1, 2014
The Clinical Trials Transformation Initiative: innovation through collaborationPamela Tenaerts, Leanne Madre, Patrick Archdeacon, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug ApplicationPatrick Archdeacon, Cheryl Grandinetti, José M Vega, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 8, 2013
Fostering innovation, advancing patient safety: the kidney health initiativePatrick Archdeacon, Rachel N Shaffer, Wolfgang C Winkelmayer, et al.
Clinical Trials (London, England)|March 28, 2017
Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trialsRaymond Perez, Patrick Archdeacon, Nancy Roach, et al.
Clinical Trials (London, England)|November 26, 2016
Understanding the functions and operations of data monitoring committees: Survey and focus group findingsKarim A Calis, Patrick Archdeacon, Raymond P Bain, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2016
Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health InitiativeLaura M Dember, Patrick Archdeacon, Mahesh Krishnan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2015
CKD as a Model for Improving Chronic Disease Care through Electronic Health RecordsPaul E Drawz, Patrick Archdeacon, Clement J McDonald, et al.
Clinical Trials (London, England)|May 16, 2017
Recommendations for data monitoring committees from the Clinical Trials Transformation InitiativeKarim A Calis, Patrick Archdeacon, Raymond Bain, et al.
Pageof 2